GSK plc (GLAXF)
USD 20.85
(0.63%)
USD 20.85
(0.63%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 4.92 Billion GBP | -67.05% |
| 2022 | 14.95 Billion GBP | 241.07% |
| 2021 | 4.38 Billion GBP | -23.73% |
| 2020 | 5.74 Billion GBP | 23.77% |
| 2019 | 4.64 Billion GBP | 28.21% |
| 2018 | 3.62 Billion GBP | 136.49% |
| 2017 | 1.53 Billion GBP | 67.98% |
| 2016 | 912 Million GBP | -89.17% |
| 2015 | 8.42 Billion GBP | 205.59% |
| 2014 | 2.75 Billion GBP | -49.3% |
| 2013 | 5.43 Billion GBP | 19.08% |
| 2012 | 4.56 Billion GBP | -13.23% |
| 2011 | 5.26 Billion GBP | 221.97% |
| 2010 | 1.63 Billion GBP | -70.46% |
| 2009 | 5.53 Billion GBP | 17.38% |
| 2008 | 4.71 Billion GBP | -9.63% |
| 2007 | 5.21 Billion GBP | -3.25% |
| 2006 | 5.38 Billion GBP | 14.93% |
| 2005 | 4.68 Billion GBP | 19.98% |
| 2004 | 3.9 Billion GBP | -12.96% |
| 2003 | 4.49 Billion GBP | 14.1% |
| 2002 | 3.93 Billion GBP | 26.94% |
| 2001 | 3.09 Billion GBP | -25.52% |
| 2000 | 4.16 Billion GBP | 129.82% |
| 1999 | 1.81 Billion GBP | -1.36% |
| 1998 | 1.83 Billion GBP | -0.76% |
| 1997 | 1.85 Billion GBP | -7.36% |
| 1996 | 1.99 Billion GBP | 36.97% |
| 1995 | 1.45 Billion GBP | 12.24% |
| 1994 | 1.29 Billion GBP | 7.62% |
| 1993 | 1.2 Billion GBP | 16.84% |
| 1992 | 1.03 Billion GBP | 17.25% |
| 1991 | 881 Million GBP | 9.17% |
| 1990 | 807 Million GBP | 17.3% |
| 1989 | 688 Million GBP | 18.42% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 1.17 Billion GBP | 12.14% |
| 2024 Q1 | 1.04 Billion GBP | 198.86% |
| 2024 Q3 | -58 Million GBP | -104.94% |
| 2023 FY | 4.92 Billion GBP | -67.05% |
| 2023 Q4 | 350 Million GBP | -76.09% |
| 2023 Q1 | 1.49 Billion GBP | 1.98% |
| 2023 Q2 | 1.62 Billion GBP | 8.99% |
| 2023 Q3 | 1.46 Billion GBP | -9.85% |
| 2022 Q3 | 10.82 Billion GBP | 1191.29% |
| 2022 Q1 | 1.8 Billion GBP | 140.59% |
| 2022 Q2 | 838 Million GBP | -53.5% |
| 2022 FY | 14.95 Billion GBP | 241.07% |
| 2022 Q4 | 1.46 Billion GBP | -86.5% |
| 2021 Q1 | 1.07 Billion GBP | 58.49% |
| 2021 Q4 | 749 Million GBP | -45.25% |
| 2021 Q3 | 1.36 Billion GBP | -1.94% |
| 2021 Q2 | 1.39 Billion GBP | 30.01% |
| 2021 FY | 4.38 Billion GBP | -23.73% |
| 2020 FY | 5.74 Billion GBP | 23.77% |
| 2020 Q4 | 677 Million GBP | -45.58% |
| 2020 Q1 | 1.56 Billion GBP | 20.48% |
| 2020 Q3 | 1.24 Billion GBP | -45.03% |
| 2020 Q2 | 2.26 Billion GBP | 44.6% |
| 2019 Q3 | 1.55 Billion GBP | 61.0% |
| 2019 Q1 | 830 Million GBP | -31.69% |
| 2019 Q4 | 1.29 Billion GBP | -16.3% |
| 2019 Q2 | 964 Million GBP | 16.14% |
| 2019 FY | 4.64 Billion GBP | 28.21% |
| 2018 Q4 | 1.21 Billion GBP | -14.32% |
| 2018 Q2 | 441 Million GBP | -19.67% |
| 2018 Q1 | 549 Million GBP | 200.55% |
| 2018 FY | 3.62 Billion GBP | 136.49% |
| 2018 Q3 | 1.41 Billion GBP | 221.54% |
| 2017 Q1 | 1.04 Billion GBP | 307.0% |
| 2017 Q3 | 1.21 Billion GBP | 773.33% |
| 2017 Q2 | -180 Million GBP | -117.21% |
| 2017 FY | 1.53 Billion GBP | 67.98% |
| 2017 Q4 | -546 Million GBP | -145.05% |
| 2016 Q1 | 282 Million GBP | 179.66% |
| 2016 Q2 | -435 Million GBP | -254.26% |
| 2016 FY | 912 Million GBP | -89.17% |
| 2016 Q3 | 808 Million GBP | 285.75% |
| 2016 Q4 | 257 Million GBP | -68.19% |
| 2015 Q3 | 538 Million GBP | 261.07% |
| 2015 Q2 | 149 Million GBP | -98.16% |
| 2015 Q1 | 8.08 Billion GBP | 683.06% |
| 2015 Q4 | -354 Million GBP | -165.8% |
| 2015 FY | 8.42 Billion GBP | 205.59% |
| 2014 Q3 | 401 Million GBP | -38.69% |
| 2014 Q4 | 1.03 Billion GBP | 157.61% |
| 2014 Q2 | 654 Million GBP | -2.1% |
| 2014 Q1 | 668 Million GBP | -72.86% |
| 2014 FY | 2.75 Billion GBP | -49.3% |
| 2013 Q4 | 2.46 Billion GBP | 153.97% |
| 2013 Q3 | 969 Million GBP | -7.27% |
| 2013 Q2 | 1.04 Billion GBP | 8.74% |
| 2013 Q1 | 961 Million GBP | 11.23% |
| 2013 FY | 5.43 Billion GBP | 19.08% |
| 2012 FY | 4.56 Billion GBP | -13.23% |
| 2012 Q4 | 864 Million GBP | -21.81% |
| 2012 Q3 | 1.1 Billion GBP | -10.74% |
| 2012 Q2 | 1.23 Billion GBP | -5.35% |
| 2012 Q1 | 1.3 Billion GBP | 4.47% |
| 2011 FY | 5.26 Billion GBP | 221.97% |
| 2011 Q2 | 1.1 Billion GBP | -27.48% |
| 2011 Q3 | 1.37 Billion GBP | 24.59% |
| 2011 Q1 | 1.52 Billion GBP | 321.01% |
| 2011 Q4 | 1.25 Billion GBP | -9.14% |
| 2010 FY | 1.63 Billion GBP | -70.46% |
| 2010 Q3 | 1.28 Billion GBP | 523.68% |
| 2010 Q4 | -690 Million GBP | -153.57% |
| 2010 Q1 | 1.34 Billion GBP | -17.79% |
| 2010 Q2 | -304 Million GBP | -122.69% |
| 2009 Q3 | 1.33 Billion GBP | -6.97% |
| 2009 FY | 5.53 Billion GBP | 17.38% |
| 2009 Q4 | 1.63 Billion GBP | 22.1% |
| 2009 Q1 | 1.13 Billion GBP | 15.17% |
| 2009 Q2 | 1.43 Billion GBP | 26.88% |
| 2008 FY | 4.71 Billion GBP | -9.63% |
| 2008 Q1 | 1.3 Billion GBP | 23.07% |
| 2008 Q4 | 982 Million GBP | -4.38% |
| 2008 Q3 | 1.02 Billion GBP | -20.14% |
| 2008 Q2 | 1.28 Billion GBP | -1.61% |
| 2007 Q2 | 1.33 Billion GBP | -11.96% |
| 2007 Q1 | 1.51 Billion GBP | 28.37% |
| 2007 Q3 | 1.31 Billion GBP | -1.72% |
| 2007 FY | 5.21 Billion GBP | -3.25% |
| 2007 Q4 | 1.06 Billion GBP | -18.93% |
| 2006 Q2 | 1.31 Billion GBP | -12.32% |
| 2006 Q4 | 1.17 Billion GBP | -15.21% |
| 2006 Q1 | 1.5 Billion GBP | 33.9% |
| 2006 Q3 | 1.39 Billion GBP | 5.73% |
| 2006 FY | 5.38 Billion GBP | 14.93% |
| 2005 Q2 | 1.18 Billion GBP | -1.22% |
| 2005 Q3 | 1.2 Billion GBP | 1.65% |
| 2005 Q4 | 1.12 Billion GBP | -7.16% |
| 2005 FY | 4.68 Billion GBP | 19.98% |
| 2005 Q1 | 1.2 Billion GBP | -0.76% |
| 2004 FY | 3.9 Billion GBP | -12.96% |
| 2004 Q4 | 1.21 Billion GBP | 20.11% |
| 2004 Q2 | 1.08 Billion GBP | 5.01% |
| 2004 Q3 | 1 Billion GBP | -7.4% |
| 2004 Q1 | 1.03 Billion GBP | 32.55% |
| 2003 Q1 | 1.2 Billion GBP | 28.4% |
| 2003 FY | 4.49 Billion GBP | 14.1% |
| 2003 Q4 | 782.32 Million GBP | -32.79% |
| 2003 Q3 | 1.16 Billion GBP | -11.9% |
| 2003 Q2 | 1.32 Billion GBP | 9.47% |
| 2002 Q4 | 940 Million GBP | 18.99% |
| 2002 Q1 | 1.02 Billion GBP | 3.14% |
| 2002 FY | 3.93 Billion GBP | 26.94% |
| 2002 Q2 | 1.17 Billion GBP | 14.91% |
| 2002 Q3 | 790 Million GBP | -32.99% |
| 2001 Q4 | 994.78 Million GBP | 163.17% |
| 2001 FY | 3.09 Billion GBP | -25.52% |
| 2001 Q1 | 700 Million GBP | -59.82% |
| 2001 Q2 | 1.02 Billion GBP | 46.71% |
| 2001 Q3 | 378 Million GBP | -63.19% |
| 2000 FY | 4.16 Billion GBP | 129.82% |
| 2000 Q1 | 793 Million GBP | 72.69% |
| 2000 Q2 | 879 Million GBP | 10.84% |
| 2000 Q3 | 748 Million GBP | -14.9% |
| 2000 Q4 | 1.74 Billion GBP | 132.89% |
| 1999 Q3 | 458.53 Million GBP | -4.21% |
| 1999 Q2 | 478.67 Million GBP | 4.81% |
| 1999 FY | 1.81 Billion GBP | -1.36% |
| 1999 Q1 | 456.69 Million GBP | -9.67% |
| 1999 Q4 | 459.19 Million GBP | 0.14% |
| 1998 Q2 | 413.34 Million GBP | 0.02% |
| 1998 Q1 | 413.27 Million GBP | 8.72% |
| 1998 Q4 | 505.59 Million GBP | 0.3% |
| 1998 FY | 1.83 Billion GBP | -0.76% |
| 1998 Q3 | 504.08 Million GBP | 21.95% |
| 1997 Q4 | 380.11 Million GBP | -9.02% |
| 1997 Q3 | 417.8 Million GBP | -18.35% |
| 1997 Q2 | 511.69 Million GBP | -1.58% |
| 1997 Q1 | 519.9 Million GBP | -38.54% |
| 1997 FY | 1.85 Billion GBP | -7.36% |
| 1996 Q4 | 845.92 Million GBP | 625.32% |
| 1996 Q3 | 116.62 Million GBP | -77.63% |
| 1996 Q1 | 530.22 Million GBP | 0.0% |
| 1996 FY | 1.99 Billion GBP | 36.97% |
| 1996 Q2 | 521.25 Million GBP | -1.69% |
| 1995 FY | 1.45 Billion GBP | 12.24% |
| 1995 Q3 | 261.4 Million GBP | -3.35% |
| 1995 Q2 | 270.46 Million GBP | 5.53% |
| 1995 Q1 | 256.29 Million GBP | -3.17% |
| 1994 FY | 1.29 Billion GBP | 7.62% |
| 1994 Q1 | 317.01 Million GBP | -12.1% |
| 1994 Q2 | 265.49 Million GBP | -16.25% |
| 1994 Q3 | 261.98 Million GBP | -1.32% |
| 1994 Q4 | 264.67 Million GBP | 1.03% |
| 1993 Q3 | 353.42 Million GBP | 38.39% |
| 1993 Q2 | 255.38 Million GBP | -28.4% |
| 1993 Q1 | 356.68 Million GBP | 21.71% |
| 1993 FY | 1.2 Billion GBP | 16.84% |
| 1993 Q4 | 360.66 Million GBP | 2.05% |
| 1992 Q3 | 249.85 Million GBP | 34.58% |
| 1992 Q4 | 293.07 Million GBP | 17.3% |
| 1992 FY | 1.03 Billion GBP | 17.25% |
| 1992 Q1 | 282.44 Million GBP | 7.51% |
| 1992 Q2 | 185.65 Million GBP | -34.27% |
| 1991 FY | 881 Million GBP | 9.17% |
| 1991 Q1 | - GBP | 0.0% |
| 1991 Q4 | 262.72 Million GBP | -6.3% |
| 1991 Q3 | 280.37 Million GBP | 0.0% |
| 1991 Q2 | - GBP | 0.0% |
| 1990 Q4 | - GBP | 0.0% |
| 1990 Q1 | - GBP | 0.0% |
| 1990 FY | 807 Million GBP | 17.3% |
| 1990 Q2 | - GBP | 0.0% |
| 1990 Q3 | - GBP | 0.0% |
| 1989 Q3 | - GBP | 0.0% |
| 1989 Q2 | - GBP | 0.0% |
| 1989 Q1 | - GBP | 0.0% |
| 1989 FY | 688 Million GBP | 18.42% |
| 1989 Q4 | - GBP | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AstraZeneca PLC | 5.95 Billion USD | 17.246% |
| Bristol-Myers Squibb Company PFD CONV 2 | 8.02 Billion USD | 38.592% |
| CSPC Pharmaceutical Group Limited | 830.91 Million USD | -493.08% |
| Clarus Therapeutics Holdings, Inc. | -56.51 Million USD | 8820.272% |
| Novartis AG | 14.85 Billion USD | 66.815% |
| PT Kalbe Farma Tbk. | 179.7 Million USD | -2642.264% |